Several studies on BRCA1 and BRCA2 mutant tumour samples have focused on genomic scars derived from inaccurate break repair.7, 8, 9 Although BRCA1/2 defect-associated SNV patterns have also been documented, cancer genomes give limited information on mutation rates. The gene discussed is BRCA1; the disease is cancer.